Paper3134490
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.
Wood CA and 8 others. J Infect Dis, 1988. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. Papers, record 3134490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3134490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Abscess | Major topic |
| Hair Cells, Auditory | Major topic |
| Kidney Diseases | Major topic |
| Pseudomonas Infections | Major topic |
| Tobramycin | Major topic |
| Animals | |
| DNA Replication | |
| Drug Administration Schedule | |
| Inflammation | |
| Inulin | |
| Kidney | |
| Pseudomonas aeruginosa | |
| Rats | |
| Rats, Inbred F344 |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41646972 | Synergy between immune system and antibiotics drives infection control in mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/41646972 | PubMed |
| 34907595 | Therapeutic evaluation of immunomodulators in reducing surgical wound infection. | FASEB J | 2022 | https://conductscience.org/library/papers/34907595 | PubMed |
| 31475156 | Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine. | Front Mol Biosci | 2019 | https://conductscience.org/library/papers/31475156 | PubMed |
| 18852271 | Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/18852271 | PubMed |
| 10803457 | A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10803457 | PubMed |
| 10390201 | Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10390201 | PubMed |
| 8950834 | Pharmacokinetics and dosing regimen of aminosidine in the dog. | Vet Res Commun | 1996 | https://conductscience.org/library/papers/8950834 | PubMed |
| 8787901 | Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787901 | PubMed |
| 8719234 | Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues. | J Pharmacokinet Biopharm | 1995 | https://conductscience.org/library/papers/8719234 | PubMed |
| 8681976 | Once-daily dosing of aminoglycosides. | Eur J Clin Microbiol Infect Dis | 1995 | https://conductscience.org/library/papers/8681976 | PubMed |
| 8611830 | Single or multiple daily doses of aminoglycosides: a meta-analysis. | BMJ | 1996 | https://conductscience.org/library/papers/8611830 | PubMed |
| 8540723 | Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8540723 | PubMed |
| 8239615 | Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239615 | PubMed |
| 8203864 | Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8203864 | PubMed |
| 8119044 | Aminoglycoside dosage regimens. Is once a day enough? | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8119044 | PubMed |
| 8067780 | Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8067780 | PubMed |
| 8067732 | Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8067732 | PubMed |
| 7955770 | What is the evidence for once-daily aminoglycoside therapy? | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7955770 | PubMed |
| 7851055 | Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7851055 | PubMed |
| 2665645 | Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2665645 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3134490
GET https://conductscience.org/api/papers/v1/3134490/cited_by?page=2